← Back to patent-cliff list
CAS 1426831-64-2
Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]-29-[[(phosphonomethyl)amino]methyl]-
Codes: TELA-009
Application context (from source-drug indications)
Ventilator-associated pneumoniaTelavancin HydrochlorideBacterial pneumoniaTelavancin HydrochlorideHospital-acquired pneumoniaTelavancin HydrochlorideHealthcare-associated pneumoniaTelavancin HydrochlorideComplicated skin and skin structure infectionTelavancin HydrochlorideStaphylococcal infectionTelavancin Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Telavancin Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(9H-fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate→Vancomycin→(aminomethyl)phosphonic acid→Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]-→Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]-29-[[(phosphonomethyl)amino]methyl]-
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.